FI85213B - Foerfarande foer framstaellning av en farmaceutisk beredning. - Google Patents

Foerfarande foer framstaellning av en farmaceutisk beredning. Download PDF

Info

Publication number
FI85213B
FI85213B FI832197A FI832197A FI85213B FI 85213 B FI85213 B FI 85213B FI 832197 A FI832197 A FI 832197A FI 832197 A FI832197 A FI 832197A FI 85213 B FI85213 B FI 85213B
Authority
FI
Finland
Prior art keywords
mixture
microcapsules
drug
release
water
Prior art date
Application number
FI832197A
Other languages
English (en)
Finnish (fi)
Other versions
FI832197A0 (fi
FI832197L (fi
FI85213C (sv
Inventor
Anders Goeran Vilh Kaellstrand
Kjell Johan Mattsson
Rolf Ivar Sjoeqvist
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of FI832197A0 publication Critical patent/FI832197A0/fi
Publication of FI832197L publication Critical patent/FI832197L/fi
Publication of FI85213B publication Critical patent/FI85213B/fi
Application granted granted Critical
Publication of FI85213C publication Critical patent/FI85213C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (3)

1. Förfarande för framställning av en bruksfärdig farma-ceutisk beredning i form av en suspension med reglerad fri-sättning av farmaceutiskt aktiv substans inklusive smaktäck-ning och ökning av stabiliteten hos den farmaceutiskt aktiva substansen, kännetecknat av att man blandar en inkapslad farmaceutisk substans med - i torr form eller i suspenderad form - vanliga hjälpämnen och en ytterligare substans för regiering av frisättningen av aktiv substans, som vilken substans användes en polysackarid, en oligosackarid, en di-sackarid, en monosackarid, en kolhydratbesläktad förening vald bland mannitol, sorbitol, glycerol, glykol, en glykosid 36 8 521 3 av en monosackarid och en substans härledd frän etylengly-kol, eller blandningar därav, i en mängd av 60-99 % (vikt/-vikt), företrädesvis 60-75 % (vikt/vikt) av den bruksfärdiga suspensionen, och tillsätter därefter vatten om blandningen är i form av torrt pulver för uppnäende av den bruksfärdiga suspensionen.
2. Förfarande enligt patentkravet 1, kännetecknat av att det som frisättningsreglerande substans användes sackaros, glukos, fruktos eller sorbitol.
4. Förfarande enligt patentkravet 1, kännetecknat av att det som aktiv substans användes bacampicillin eller teofyl-lin.
FI832197A 1982-06-24 1983-06-16 Förfarande för framställning av en farmaceutisk beredning FI85213C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8203953A SE8203953D0 (sv) 1982-06-24 1982-06-24 Pharmaceutical mixture
SE8203953 1982-06-24

Publications (4)

Publication Number Publication Date
FI832197A0 FI832197A0 (fi) 1983-06-16
FI832197L FI832197L (fi) 1983-12-25
FI85213B true FI85213B (fi) 1991-12-13
FI85213C FI85213C (sv) 1992-03-25

Family

ID=20347191

Family Applications (1)

Application Number Title Priority Date Filing Date
FI832197A FI85213C (sv) 1982-06-24 1983-06-16 Förfarande för framställning av en farmaceutisk beredning

Country Status (29)

Country Link
EP (1) EP0101418B1 (sv)
JP (1) JPS5916822A (sv)
KR (1) KR910000028B1 (sv)
AR (1) AR231075A1 (sv)
AT (1) ATE59286T1 (sv)
AU (1) AU561954B2 (sv)
BG (1) BG51341A3 (sv)
CA (1) CA1214726A (sv)
CS (1) CS257769B2 (sv)
CY (1) CY1468A (sv)
DD (1) DD209971A5 (sv)
DE (1) DE3382086D1 (sv)
DK (1) DK161365C (sv)
ES (1) ES523536A0 (sv)
FI (1) FI85213C (sv)
GB (1) GB2122490B (sv)
GR (1) GR78604B (sv)
HK (1) HK98786A (sv)
HU (1) HU189300B (sv)
IE (1) IE55204B1 (sv)
IS (1) IS1325B6 (sv)
MY (1) MY8700292A (sv)
NO (1) NO168745C (sv)
NZ (1) NZ204639A (sv)
PH (1) PH21911A (sv)
PT (1) PT76919B (sv)
SE (1) SE8203953D0 (sv)
SU (1) SU1722207A3 (sv)
ZA (1) ZA833931B (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0729927B2 (ja) * 1983-04-09 1995-04-05 日研化学株式会社 テオフィリン徐放性製剤
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
IT1183575B (it) * 1985-05-08 1987-10-22 Eurand Spa Formulazione deodorando ad effetto modulante sulla trfaspirazione
NL8503539A (nl) * 1986-01-02 1987-07-16 Warner Lambert Co Sucrose-vrije preparaten.
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US5427935A (en) * 1987-07-24 1995-06-27 The Regents Of The University Of Michigan Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes
SE463542B (sv) * 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer instanticerbar produkt samt foerfarande foer dess framstaellning
JPH03504968A (ja) * 1988-04-19 1991-10-31 サウスウェスト・リサーチ・インスティチュート 塩感受性シェル物質を有するカプセルからの活性成分の制御放出
US5064650A (en) * 1988-04-19 1991-11-12 Southwest Research Institute Controlled-release salt sensitive capsule for oral use and adhesive system
FR2653337B1 (fr) * 1989-10-23 1992-02-07 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5364634A (en) * 1991-11-08 1994-11-15 Southwest Research Institute Controlled-release PH sensitive capsule and adhesive system and method
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
DE4312656C2 (de) * 1993-04-19 1996-01-25 Beiersdorf Ag Kühlend wirkende kosmetische oder dermatologische Zusammensetzungen
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
JP3470198B2 (ja) * 1995-05-02 2003-11-25 大正製薬株式会社 経口投与用組成物
DE19706978A1 (de) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Kombinationspräparat für oral applizierbare Antibiotika
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297088A (sv) * 1961-01-31
US3689654A (en) * 1970-09-14 1972-09-05 Morton Norwich Products Inc Pharmaceutical compositions
ES434971A1 (es) * 1974-02-22 1977-05-16 Wellcome Found Metodo para producir un preparado farmaceutico que comprendeuna solucin de digoxina en una envolvente de capsula solu- ble.
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
JPS57209223A (en) * 1981-06-19 1982-12-22 Tanabe Seiyaku Co Ltd Microcapsule for intracranial anti hypotension and its production

Also Published As

Publication number Publication date
ATE59286T1 (de) 1991-01-15
FI832197A0 (fi) 1983-06-16
CY1468A (en) 1989-07-21
ZA833931B (en) 1984-07-25
GR78604B (sv) 1984-09-27
AR231075A1 (es) 1984-09-28
DK161365C (da) 1991-12-09
JPS5916822A (ja) 1984-01-28
GB2122490A (en) 1984-01-18
ES8403720A1 (es) 1984-04-01
JPH0559089B2 (sv) 1993-08-30
BG51341A3 (en) 1993-04-15
CA1214726A (en) 1986-12-02
SE8203953D0 (sv) 1982-06-24
HU189300B (en) 1986-06-30
EP0101418A3 (en) 1984-11-14
AU561954B2 (en) 1987-05-21
AU1594383A (en) 1984-01-05
HK98786A (en) 1986-12-24
EP0101418B1 (en) 1990-12-27
NZ204639A (en) 1986-01-24
NO832293L (no) 1983-12-27
DK272383A (da) 1983-12-25
NO168745B (no) 1991-12-23
IE55204B1 (en) 1990-07-04
MY8700292A (en) 1987-12-31
PT76919B (en) 1986-04-09
DE3382086D1 (de) 1991-02-07
IE831462L (en) 1983-12-24
FI832197L (fi) 1983-12-25
PH21911A (en) 1988-04-08
SU1722207A3 (ru) 1992-03-23
IS2824A7 (is) 1983-12-25
PT76919A (en) 1983-07-01
NO168745C (no) 1992-04-01
IS1325B6 (is) 1988-08-03
GB2122490B (en) 1986-04-03
FI85213C (sv) 1992-03-25
ES523536A0 (es) 1984-04-01
KR840005024A (ko) 1984-11-03
EP0101418A2 (en) 1984-02-22
DD209971A5 (de) 1984-05-30
KR910000028B1 (ko) 1991-01-19
GB8317071D0 (en) 1983-07-27
DK161365B (da) 1991-07-01
CS463683A2 (en) 1987-11-12
CS257769B2 (en) 1988-06-15
DK272383D0 (da) 1983-06-14

Similar Documents

Publication Publication Date Title
FI85213B (fi) Foerfarande foer framstaellning av en farmaceutisk beredning.
US4994260A (en) Pharmaceutical mixture
JP2653996B2 (ja) 徐放性薬剤
AU737818B2 (en) Gastroretentive controlled release microspheres for improved drug delivery
ES2307739T3 (es) Sales farmaceuticas de compuestos 1-fenil-3-dimetilamino-propano.
JP4184278B2 (ja) 非ゼラチン系カプセル皮膜組成物及びそれを用いたカプセル
FI80589C (sv) Förfarande för framställning av ett torrt pulver för en farmaceutisk m ixturberedning, vilket pulver innehåller mikroinkapslad bacampicillin- hydroklorid
EP0391518B1 (en) Sustained-release pharmaceutical preparation
DE69924735T2 (de) Zur wirkstoffabgabe an zielorten im darm fähige zubereitung
US20050181047A1 (en) Compositions and methods for timed release of water-soluble nutritional supplements
US20080107725A1 (en) Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
CN103228267A (zh) 治疗膀胱过动症的药物制剂
JPH02167220A (ja) 天然ポリマーを用いた徐放性製剤
AU1010500A (en) Controlled Release Tramadol Preparations Having a Storage- stable Release Profile and Process for the Production Thereof
JPH082783B2 (ja) 新規な投与形態
GB2134785A (en) Slow-release compositions
US4832955A (en) Controlled release potassium chloride composition
CA2324363A1 (en) Coated starch capsules and a process for producing them
US20050196445A1 (en) Edible microcrystalline cellulose and carrageenan coating composition
WO1998015265A1 (en) Colonic delivery of weak acid drugs
AU2012326513B2 (en) Two phase pharmaceutical delivery system
WO2004108164A1 (ja) コーティング用組成物およびコーティング製剤
EP1238663A2 (en) Mixed hydrophilic gels as controlled release vehicles or floating dispersants
CZ420399A3 (cs) Gastroretenční mikrosféry s regulovaným ulolňováním a zlepšenou dodávkou účinné látky

Legal Events

Date Code Title Description
MA Patent expired

Owner name: ASTRA LAEKEMEDEL AKTIEBOLAG